Detalhe da pesquisa
1.
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
J Infect Dis
; 220(11): 1802-1815, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402384